Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study-Reference-Cited by-同舟云学术

Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study

Published:2009-05-21 Issue:2 Volume:24 Page:93-103
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Palatini P,Jung W,Shlyakhto E,Botha J,Bush C,Keefe D L

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/jhh200938.pdf

Reference18 articles.

1. Burnier M . Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19: 1190–1196.

2. Egan BM, Lackland DT, Cutler NE . Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med 2003; 163: 681–687.

3. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407–2415.

4. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M . Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114–1117.

5. Frampton JE, Curran MP . Aliskiren: a review of its use in the management of hypertension. Drugs 2007; 67: 1767–1792.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis;Annals of Medicine;2024-06-03

2. How drug onset rate and duration of action affect drug forgiveness;Journal of Pharmacokinetics and Pharmacodynamics;2024-01-10

3. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension;Cochrane Database of Systematic Reviews;2020-10-22

4. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics;European Journal of Clinical Pharmacology;2020-09-29

5. The use of aliskiren as an antifibrotic drug in experimental models: A systematic review;Drug Development Research;2019-10-12